Patient-reported outcomes in the context of the benefit assessment in Germany

Sarah Böhme, Christoph Gerlinger, Susanne Huschens +7

Since the 2011 Act on the Reform of the Market for Medicinal Products, benefit dossiers are submitted by pharmaceutical companies to facilitate the Health Technology Assessment (HT…